Farmingdale, NY, January 25, 2018 – Enzo Clinical Labs, Inc. (NYSE: ENZ) today announced the launch of its AMPIPROBE® Women’s Health Panel, a molecular diagnostic test that allows for the detection of 13 pathogens associated with women’s health and sexually transmitted diseases on a single collection device.
The AMPIPROBE® Women’s Health Panel is a highly sensitive and specific multiplex nucleic acid amplification test developed with Enzo’s proprietary technology. It is one of the most comprehensive women’s health panels on the market as it allows for the detection of Bacterial Vaginosis (BV), Trichomoniasis (TV), Vulvovaginal Candidiasis (VVC) and sexually transmitted infections such as Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG).
The ability to detect and differentiate Candida species (C. albicans, C. glabrata, C. krusei, C. parapsilosis and C. tropicalis) from Trichomonas vaginalis and bacteria associated with the vaginal microbiome such as Lactobacillus spp., as well as bacteria associated with bacterial vaginosis (Atopobium vaginae, Gardnerella vaginalis, Megasphaera-1, BVAB-2), will significantly help the clinical management of vaginitis. Moreover, it will reduce the stress on the patient to provide different specimens for multiple tests as this test requires a single swab specimen collection.
The AMPIPROBE® Women's Health Panel highlights Enzo’s ability to develop high performance, open, adaptable and cost-effective products and services. Enzo is uniquely able to create affordable solutions for the diagnostics market due to its nature as an integrated diagnostics company, which encompasses technology development, manufacturing, clinical validation and commercialization, and advanced state-of-the-art diagnostic laboratory and reference services.
About Enzo Clinical Labs
Enzo Clinical Labs, Inc. is a wholly owned subsidiary of Enzo Biochem, Inc. headquartered in Farmingdale, NY. Enzo Clinical Labs is a full-service clinical reference laboratory with 40 plus years of experience in improving healthcare through innovative technology, with a focus on women’s health. Our extensive molecular technology and capabilities support our clinical diagnostic services for both labs and physicians. We are a committed partner with quick turnaround times and unparalleled patient satisfaction. Our laboratory utilizes the latest in connectivity solutions to allow rapid, accurate, and secure data transmission. We maintain 24/7/365 clinical operation supported by STAT labs, a network of patient service centers, in-house logistics, phlebotomy, and translational diagnostics. With our highly-qualified, dedicated team, our commitment to world-class service is unsurpassed in the industry.
Kara Cannon, Global Head of Marketing
1-631.694.7070 x 1301